lunedì, 4 maggio 2026

Notizie Newsletter

Elotuzumab Triplet Approved in Europe for Multiple Myeloma

Aug 27, 2019 - The European Commission has approved elotuzumab for use in combination with pomalidomide and low-dose dexamethasone (EPd) for the treatment of patients with relapsed/refractory multiple myeloma following 2 or more prior therapies, including lenalidomide and ...
Leggi tutto

Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508

Pemetrexed or bevacizumab is used for maintenance therapy of advanced nonsquamous non–small-cell lung cancer (NSCLC). The combination of bevacizumab and pemetrexed has also demonstrated efficacy. We conducted a randomized study to determine the optimal maintenance ...
Leggi tutto

26 agosto 2019 – Epatite C: aggiornamento del 26/08/2019 sui pazienti arruolati

Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study

The study aimed to investigate if assisted reproductive technology (ART) treatment or a diagnosis of infertility were associated with the risk of ovarian cancer or borderline ovarian tumors (BOT) in parous women. In a population-based register study of 1,340,097 women with ...
Leggi tutto

FDA Wants Male Patients Factored Into Breast Cancer Drug Development

Aug 21, 2019 - The FDA is hoping to improve the armamentarium for male patients with breast cancer through the issuance of industry guidelines aimed at encouraging the inclusion of male patients in breast cancer clinical trials. The industry guidelines, which are still in ...
Leggi tutto

Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery

To compare clinical outcomes for stage IIIC and IV ovarian cancer patients receiving neoadjuvant chemotherapy and interval cytoreductive surgery followed by up to three versus more cycles of post-operative chemotherapy. We conducted a multi-institution retrospective cohort ...
Leggi tutto

TAS-102 Nabs Japanese Approval for Gastric Cancer

Aug 23, 2019 - The Japanese Ministry of Health, Labour and Welfare has approved TAS-102 (trifluridine/tipiracil) for the treatment of patients with unresectable advanced or recurrent gastric cancer that has progressed after chemotherapy, according to Taiho Pharmaceutical ...
Leggi tutto

EMA/FDA analysis shows high degree of alignment in marketing application decisions between EU and US

Aug 16, 2019 - EMA and the US Food and Drug Administration (FDA) are aligned in more than 90% of marketing authorisation decisions for new medicines. This is one of the findings of a joint EMA/FDA analysis comparing decisions on 107 new medicine applications at the two agencies ...
Leggi tutto

FDA proposes new required health warnings with color images for cigarette packages and advertisements to promote greater public understanding of negative health consequences of smoking

Aug 15, 2019 - Today, the U.S. Food and Drug Administration issued a proposed rule to require new health warnings on cigarette packages and in advertisements to promote greater public understanding of the negative health consequences of smoking. The proposed warnings, which ...
Leggi tutto

NCCN Guidelines Set New Pace for Pediatric ALL

Aug 4, 2019 - With the recent publication of an inaugural set of guidelines for treatment of pediatric acute lymphoblastic leukemia (ALL), the National Comprehensive Cancer Network (NCCN) seeks to introduce standards to a branch of care long dominated by clinical trial protocols. ...
Leggi tutto